News
New Preprint: sctrial — Participant-Level Differential Analysis for Longitudinal Single-Cell Experiments
April 6, 2026
We are excited to share our new preprint, “sctrial: Participant-Level Differential Analysis for Longitudinal Single-Cell Experiments,” now available on bioRxiv.
Read more →New Preprint: THR-6E for Risk Stratification in ER+/HER2− Breast Cancer
February 3, 2026
We are excited to share our new preprint, “THR-6E: A Six-Gene Cell-of-Origin Signature Stratifies Risk and Predicts Systemic Therapy Response in ER+/HER2− Breast Cancer,” now available on medRxiv.
Read more →Omar Lab Presents at the NRG Oncology 2026 Winter Meeting
January 23, 2026
Dr. Mohamed Omar presented at the NRG Oncology 2026 Winter Meeting in San Francisco, delivering two talks on THR-based signatures for forecasting clinical outcome and treatment response in breast cancer.
Read more →New Subaward to Advance Multi-Omics Integration
October 28, 2025
We are pleased to announce that the Omar Lab has received a subaward from the National Institutes of Health and City University of New York (CUNY) to support the development of cross-platform analytical frameworks for multi-omics integration and digital pathology.
Read more →New DoD Award to Decode Bone Metastasis in Prostate Cancer
August 6, 2025
We are excited to share that the Omar Lab has received a U.S. Department of Defense Prostate Cancer Research Program (PCRP) Idea Development Award to support our ongoing efforts to understand and predict bone metastasis in prostate cancer.
Read more →